{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:39:52Z","timestamp":1791772792815,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005089","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7202136"],"award-info":[{"award-number":["7202136"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["2060302"],"award-info":[{"award-number":["2060302"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences & Peking Union Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-1-029"],"award-info":[{"award-number":["2021-I2M-1-029"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jare.2025.04.045","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:15:35Z","timestamp":1746184535000},"page":"1083-1098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Construction of safer hirudin-derived peptides with enhanced anticoagulant properties based on C-terminal active residue adaptation and modification"],"prefix":"10.1016","volume":"80","author":[{"given":"Xiaozhe","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5116-6128","authenticated-orcid":false,"given":"Xiaoli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhuan","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5272-8405","authenticated-orcid":false,"given":"Linchun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10446","key":"10.1016\/j.jare.2025.04.045_b0005","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","article-title":"Stroke","volume":"403","author":"Hilkens","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jare.2025.04.045_b0010","first-page":"496","article-title":"Pharmacodynamic advantages and characteristics of traditional Chinese medicine in prevention and treatment of ischemic stroke","volume":"15","author":"Zhang","year":"2023","journal-title":"Chin Herb Med"},{"issue":"11","key":"10.1016\/j.jare.2025.04.045_b0015","first-page":"785","article-title":"Thrombosis and platelets: an update","volume":"38","author":"Koupenova","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jare.2025.04.045_b0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12959-022-00392-0","article-title":"Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background","volume":"20","author":"van Paridon","year":"2022","journal-title":"Thromb J"},{"issue":"6","key":"10.1016\/j.jare.2025.04.045_b0025","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/bja\/88.6.848","article-title":"Thrombin generation and its inhibition: a review of the scientific basis and mechanism of action of anticoagulant therapies","volume":"88","author":"Walker","year":"2002","journal-title":"Br J Anaesth"},{"issue":"7","key":"10.1016\/j.jare.2025.04.045_b0030","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCRESAHA.112.264903","article-title":"Translational success stories: development of direct thrombin inhibitors","volume":"111","author":"Coppens","year":"2012","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.jare.2025.04.045_b0035","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1160\/TH09-11-0758","article-title":"Dabigatran etexilate\u2013a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity","volume":"103","author":"van Ryn","year":"2010","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.jare.2025.04.045_b0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1055\/s-2007-996128","article-title":"Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor","volume":"23","author":"Hursting","year":"1997","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.jare.2025.04.045_b0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1517\/17425250902845646","article-title":"Pharmacological and clinical profile of bivalirudin in the treatment of patients with acute coronary syndrome","volume":"5","author":"White","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"7","key":"10.1016\/j.jare.2025.04.045_b0050","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrcardio.2012.61","article-title":"Direct thrombin inhibitors in cardiovascular disease","volume":"9","author":"Arsenault","year":"2012","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.jare.2025.04.045_b0055","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1055\/s-2007-1002723","article-title":"Biochemistry and genetic engineering of hirudin","volume":"15","author":"Johnson","year":"1989","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jare.2025.04.045_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.660757","article-title":"Pharmacological activities and mechanisms of hirudin and its derivatives - a review","volume":"12","author":"Junren","year":"2021","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.jare.2025.04.045_b0065","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1055\/s-0037-1616750","article-title":"Identification of critical residues on thrombin mediating its interaction with fibrin","volume":"86","author":"Hall","year":"2001","journal-title":"Thromb Haemostasis"},{"issue":"10","key":"10.1016\/j.jare.2025.04.045_b0070","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1021\/jm901743x","article-title":"Leech-derived thrombin inhibitors: from structures to mechanisms to clinical applications","volume":"53","author":"Corral-Rodr\u00edguez","year":"2010","journal-title":"J Med Chem"},{"issue":"23","key":"10.1016\/j.jare.2025.04.045_b0075","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.jcin.2016.09.020","article-title":"Use and effectiveness of bivalirudin versus unfractionated heparin for percutaneous coronary intervention among patients with st-segment elevation myocardial infarction in the United States","volume":"9","author":"Secemsky","year":"2016","journal-title":"JACC-Cardiovasc Inte"},{"issue":"30","key":"10.1016\/j.jare.2025.04.045_b0080","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1021\/bi00482a021","article-title":"Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin","volume":"29","author":"Maraganore","year":"1990","journal-title":"Biochemistry"},{"issue":"29","key":"10.1016\/j.jare.2025.04.045_b0085","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1021\/bi00029a032","article-title":"Core domain of hirudin from the leech Hirudinaria manillensis: chemical synthesis, purification, and characterization of a Trp3 analog of fragment 1-47","volume":"34","author":"De Filippis","year":"1995","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.jare.2025.04.045_b0090","first-page":"819","article-title":"The direct thrombin inhibitor hirudin","volume":"99","author":"Greinacher","year":"2008","journal-title":"Thromb Haemostasis"},{"issue":"14","key":"10.1016\/j.jare.2025.04.045_b0095","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1111\/bph.15816","article-title":"Molecular dynamic and pharmacological studies on protein-engineered hirudin variants of Hirudinaria manillensis and Hirudo medicinalis","volume":"179","author":"Sun","year":"2022","journal-title":"Brit J Pharmacol"},{"issue":"11","key":"10.1016\/j.jare.2025.04.045_b0100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314349121","article-title":"In situ formed depot of elastin-like polypeptide-hirudin fusion protein for long-acting antithrombotic therapy","volume":"121","author":"Tian","year":"2024","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.jare.2025.04.045_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118257","article-title":"Exploring a Hirudin variant from nonhematophagous leeches: Unraveling full-length sequence, alternative splicing, function, and potential as a novel anticoagulant polypeptide","volume":"330","author":"Yi","year":"2024","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.jare.2025.04.045_b0110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/blood.V75.2.399.bloodjournal752399","article-title":"Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin","volume":"75","author":"Jakubowski","year":"1990","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.jare.2025.04.045_b0115","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1021\/acs.accounts.3c00388","article-title":"Exploiting chemical protein synthesis to study the role of tyrosine sulfation on anticoagulants from hematophagous organisms","volume":"56","author":"Maxwell","year":"2023","journal-title":"Acc Chem Res"},{"issue":"D1","key":"10.1016\/j.jare.2025.04.045_b0120","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the universal protein knowledgebase in 2023","volume":"51","author":"Consortium TU","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10.1016\/j.jare.2025.04.045_b0125","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol Biol Evol"},{"issue":"9","key":"10.1016\/j.jare.2025.04.045_b0130","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2-a multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.jare.2025.04.045_b0135","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/bioinformatics\/18.5.769","article-title":"The Sulfinator: predicting tyrosine sulfation sites in protein sequences","volume":"18","author":"Monigatti","year":"2002","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.jare.2025.04.045_b0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci"},{"issue":"7","key":"10.1016\/j.jare.2025.04.045_b0145","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41592-020-0848-2","article-title":"Macromolecular modeling and design in Rosetta: recent methods and frameworks","volume":"17","author":"Leman","year":"2020","journal-title":"Nat Methods"},{"issue":"21","key":"10.1016\/j.jare.2025.04.045_b0150","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1021\/acs.jpcb.7b11367","article-title":"Flex ddG: rosetta ensemble-based estimation of changes in protein-protein binding affinity upon mutation","volume":"122","author":"Barlow","year":"2018","journal-title":"J Phys Chem B"},{"issue":"11","key":"10.1016\/j.jare.2025.04.045_b0155","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.molp.2023.09.010","article-title":"TBtools-II: A \u201cone for all, all for one\u201d bioinformatics platform for biological big-data mining","volume":"16","author":"Chen","year":"2023","journal-title":"Mol Plant"},{"issue":"13","key":"10.1016\/j.jare.2025.04.045_b0160","doi-asserted-by":"crossref","DOI":"10.1063\/5.0018516","article-title":"Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS","volume":"153","author":"P\u00e1ll","year":"2020","journal-title":"J Chem Phys"},{"issue":"1","key":"10.1016\/j.jare.2025.04.045_b0165","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12859-023-05246-8","article-title":"ICOR: improving codon optimization with recurrent neural networks","volume":"24","author":"Jain","year":"2023","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.jare.2025.04.045_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.109208","article-title":"Identification, isoform classification, ligand binding, and database construction of the protein-tyrosine sulfotransferase family in metazoans","volume":"182","author":"Yi","year":"2024","journal-title":"Comput Biol Med"},{"issue":"9","key":"10.1016\/j.jare.2025.04.045_b0175","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41594-021-00650-1","article-title":"AlphaFold2 and the future of structural biology","volume":"28","author":"Cramer","year":"2021","journal-title":"Nat Struct Mol Biol"},{"issue":"9","key":"10.1016\/j.jare.2025.04.045_b0180","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/s41592-022-01585-1","article-title":"US-align: universal structure alignments of proteins, nucleic acids, and macromolecular complexes","volume":"19","author":"Zhang","year":"2022","journal-title":"Nat Methods"},{"issue":"9","key":"10.1016\/j.jare.2025.04.045_b0185","doi-asserted-by":"crossref","first-page":"11633","DOI":"10.1021\/acsomega.7b01533","article-title":"Preparation of tyrosylprotein sulfotransferases for in vitro one-pot enzymatic synthesis of sulfated proteins\/peptides","volume":"3","author":"Wang","year":"2018","journal-title":"ACS Omega"},{"issue":"7","key":"10.1016\/j.jare.2025.04.045_b0190","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"issue":"5","key":"10.1016\/j.jare.2025.04.045_b0195","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF01982887","article-title":"Carrageenin-induced thrombosis in rats and mice: a model for testing antithrombotic substances?","volume":"16","author":"Bekemeier","year":"1985","journal-title":"Agents Actions"},{"issue":"7","key":"10.1016\/j.jare.2025.04.045_b0200","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"issue":"41","key":"10.1016\/j.jare.2025.04.045_b0205","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc0382","article-title":"Self-regulated hirudin delivery for anticoagulant therapy","volume":"6","author":"Xu","year":"2020","journal-title":"Sci Adv"},{"issue":"19","key":"10.1016\/j.jare.2025.04.045_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910282","article-title":"Methamphetamine-induced blood pressure sensitization correlates with morphological alterations within A1\/C1 catecholamine neurons","volume":"25","author":"Busceti","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jare.2025.04.045_b0215","first-page":"137","article-title":"Zinc chelation promotes streptokinase-induced thrombolysis in vitro","volume":"9","author":"Wang","year":"2017","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"12","key":"10.1016\/j.jare.2025.04.045_b0220","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.1016\/S2352-3026(24)00281-3","article-title":"Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants","volume":"11","author":"Ageno","year":"2024","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.jare.2025.04.045_b0225","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","article-title":"Therapeutic strategies for thrombosis: new targets and approaches","volume":"19","author":"Mackman","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.jare.2025.04.045_b0230","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.bja.2018.01.023","article-title":"Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review","volume":"120","author":"Boer","year":"2018","journal-title":"Br J Anaesth"},{"issue":"2 Suppl","key":"10.1016\/j.jare.2025.04.045_b0235","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jare.2025.04.045_b0240","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1182\/blood-2006-02-001057","article-title":"Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin","volume":"108","author":"Tardy","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jare.2025.04.045_b0245","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1021\/acs.chemrev.5b00583","article-title":"Experimental binding energies in supramolecular complexes","volume":"116","author":"Biedermann","year":"2016","journal-title":"Chem Rev"},{"issue":"4","key":"10.1016\/j.jare.2025.04.045_b0250","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1021\/ar300265y","article-title":"The cation-\u03c0 interaction","volume":"46","author":"Dougherty","year":"2013","journal-title":"Acc Chem Res"},{"issue":"35","key":"10.1016\/j.jare.2025.04.045_b0255","doi-asserted-by":"crossref","first-page":"10648","DOI":"10.1021\/ja0735002","article-title":"Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin","volume":"129","author":"Liu","year":"2007","journal-title":"J Am Chem Soc"},{"issue":"4","key":"10.1016\/j.jare.2025.04.045_b0260","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1021\/acs.chemrev.7b00305","article-title":"Electrostatic interactions in protein structure, folding, binding, and condensation","volume":"118","author":"Zhou","year":"2018","journal-title":"Chem Rev"},{"issue":"11","key":"10.1016\/j.jare.2025.04.045_b0265","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/nbt1254","article-title":"Recombinant expression of selectively sulfated proteins in Escherichia coli","volume":"24","author":"Liu","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.jare.2025.04.045_b0270","article-title":"Unleashing the potential of noncanonical amino acid biosynthesis to create cells with precision tyrosine sulfation","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.04.045_b0275","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/ncomms2593","article-title":"Crystal structure of human tyrosylprotein sulfotransferase-2 reveals the mechanism of protein tyrosine sulfation reaction","volume":"4","author":"Teramoto","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.04.045_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125957","article-title":"End-on PEGylation of heparin: Effect on anticoagulant activity and complexation with protamine","volume":"249","author":"Amaral","year":"2023","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"10.1016\/j.jare.2025.04.045_b0285","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/iub.461","article-title":"Structural basis of thrombin-protease-activated receptor interactions","volume":"63","author":"Gandhi","year":"2011","journal-title":"IUBMB Life"},{"issue":"6801","key":"10.1016\/j.jare.2025.04.045_b0290","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.jare.2025.04.045_b0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612920","article-title":"Comparative thrombin generation in animal plasma: sensitivity to human factor XIa and tissue factor","volume":"24","author":"Liang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.jare.2025.04.045_b0300","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/jth.13441","article-title":"Coagulation and non-coagulation effects of thrombin","volume":"14","author":"Posma","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.jare.2025.04.045_b0305","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrneph.2015.177","article-title":"The emerging role of coagulation proteases in kidney disease","volume":"12","author":"Madhusudhan","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.jare.2025.04.045_b0310","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.thromres.2013.09.040","article-title":"Managing pulmonary embolism from presentation to extended treatment","volume":"133","author":"Cohen","year":"2014","journal-title":"Thromb Res"},{"issue":"13","key":"10.1016\/j.jare.2025.04.045_b0315","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2165\/00003495-200262130-00001","article-title":"Management of patients with acute coronary syndromes: what is the clinical role of direct thrombin inhibitors?","volume":"62","author":"Eikelboom","year":"2002","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.jare.2025.04.045_b0320","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/all.15210","article-title":"Thrombin cleaves IL-33 and modulates IL-33-activated allergic lung inflammation","volume":"77","author":"Huang","year":"2022","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.jare.2025.04.045_b0325","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2165\/00003495-200868120-00007","article-title":"Dabigatran etexilate","volume":"68","author":"Sanford","year":"2008","journal-title":"Drugs"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225002899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225002899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:18:34Z","timestamp":1769822314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225002899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":65,"alternative-id":["S2090123225002899"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.04.045","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction of safer hirudin-derived peptides with enhanced anticoagulant properties based on C-terminal active residue adaptation and modification","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.04.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}